4//SEC Filing
Radovich Peter 4
Accession 0001415889-25-006955
CIK 0001759425other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:28 PM ET
Size
6.5 KB
Accession
0001415889-25-006955
Insider Transaction Report
Form 4
Radovich Peter
PRESIDENT AND COO
Transactions
- Sale
Common Stock
2025-03-04$45.57/sh−13,681$623,458→ 13,280 total - Sale
Common Stock
2025-03-04$45.74/sh−1,169$53,470→ 12,111 total
Footnotes (1)
- [F1]The weighted average sale price for the transaction reported was $45.571143, and the range of prices were between $45.50 and $45.88. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Documents
Issuer
Mirum Pharmaceuticals, Inc.
CIK 0001759425
Entity typeother
Related Parties
1- filerCIK 0001650131
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:28 PM ET
- Size
- 6.5 KB